Back to BlackRock, Inc.

XENE
6 quarters

Position history for BlackRock, Inc.'s holdings in XENON PHARMACEUTICALS INC

BlackRock, Inc. holds 5.6M shares of XENE (XENON PHARMACEUTICALS INC), worth $328M as of 2026-Q1. The position was increased (+10.6% shares). XENE represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$328M

Current Shares

5.6M

Total Value Change

+$245.4M

Total Shares Change

+3.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.6M
+10.6%
$328M0.0%$43.79
34
2025-Q4
Increased
5.1M
+6.9%
$228.6M0.0%$44.12
33
2025-Q3
Decreased
4.8M
-11.1%
$191.6M0.0%$39.06
0
2025-Q2
Increased
5.4M
+163.5%
$167.9M0.0%$32.40
49
2025-Q1
Decreased
2M
-3.3%
$68.3M0.0%$34.26
0
2024-Q4
New
2.1M
-
$82.5M0.0%$38.53
41

Other major holders of XENE: FMR LLC, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used